Iza-bren Shows Efficacy in Advanced TNBC
Subcutaneous Amivantamab Earns Breakthrough Therapy Designation in HNSCC
| Read More |
Neoadjuvant Chemo/Nivolumab Yields Deep Responses in Borderline-Resectable PDAC Subset
| Read More |
NEW VIDEO
.png?width=800&upscale=true&name=Video%20Asset%20Deck%20Template%20(TCT%20Comp).png) What were the key lymphoma takeaways from the 2026 Tandem Meetings?
|
Videos
 Facilitating Commercialization Through Collaboration in Oncology
|
 Eliminating Bias and Ethically Integrating AI for Palliative Oncology Care
|
Trending
 What Were the Key Abstracts and Presentations at The 2026 Tandem Meetings?
|
 Highlighting Emerging Technologies in CNS Radiation Oncology
|